116 related articles for article (PubMed ID: 26229233)
21. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
Rupérez M; González R; Mombo-Ngoma G; Kabanywanyi AM; Sevene E; Ouédraogo S; Kakolwa MA; Vala A; Accrombessi M; Briand V; Aponte JJ; Manego Zoleko R; Adegnika AA; Cot M; Kremsner PG; Massougbodji A; Abdulla S; Ramharter M; Macete E; Menéndez C
PLoS Med; 2016 Feb; 13(2):e1001964. PubMed ID: 26905278
[TBL] [Abstract][Full Text] [Related]
22. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK
Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of antenatal intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine on peripartum outcomes.
Godwin IO; Ekejindu IM; Eleje GU; Ezeagwuna DA; Okafor CG; Onwuegbuna AA; Umeononihu OS; Godwin PO; Ogelle OM; Ikechebelu JI
Ther Adv Infect Dis; 2022; 9():20499361221122620. PubMed ID: 36089984
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of malaria parasitaemia and malaria related anaemia among pregnant women in Abakaliki, South East Nigeria.
Nwonwu EU; Ibekwe PC; Ugwu JI; Obarezi HC; Nwagbara OC
Niger J Clin Pract; 2009 Jun; 12(2):182-6. PubMed ID: 19764671
[TBL] [Abstract][Full Text] [Related]
26. Adherence to intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine and outcome of pregnancy among parturients in South East Nigeria.
Onyebuchi AK; Lawani LO; Iyoke CA; Onoh CR; Okeke NE
Patient Prefer Adherence; 2014; 8():447-52. PubMed ID: 24741295
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
[TBL] [Abstract][Full Text] [Related]
28. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.
Onyeneho NG; Orji BC; Okeibunor JC; Brieger WR
Int J Gynaecol Obstet; 2013 Nov; 123(2):101-4. PubMed ID: 24041469
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
Ndeserua R; Juma A; Mosha D; Chilongola J
Afr Health Sci; 2015 Sep; 15(3):810-8. PubMed ID: 26957969
[TBL] [Abstract][Full Text] [Related]
32. Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
Msyamboza KP; Savage EJ; Kazembe PN; Gies S; Kalanda G; D'Alessandro U; Brabin BJ
Trop Med Int Health; 2009 Feb; 14(2):183-9. PubMed ID: 19207178
[TBL] [Abstract][Full Text] [Related]
33. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
Siame MN; Mharakurwa S; Chipeta J; Thuma P; Michelo C
Malar J; 2015 May; 14():190. PubMed ID: 25943379
[TBL] [Abstract][Full Text] [Related]
35. Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.
Mbonye AK; Hansen KS; Bygbjerg IC; Magnussen P
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):685-93. PubMed ID: 18513767
[TBL] [Abstract][Full Text] [Related]
36. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
[TBL] [Abstract][Full Text] [Related]
37. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence of maternal and placental malaria and of neonatal low birth weight in a semi-urban area of Bamako (Mali)].
Famanta A; Diakite M; Diawara SI; Diakité SA; Doumbia S; Traoré K; Konaté DS; Doumbia M; Keita AS; Thiéro D; Traoré SF; Doumbia S; Tounkara A
Sante; 2011; 21(1):3-7. PubMed ID: 21700554
[TBL] [Abstract][Full Text] [Related]
39. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
[TBL] [Abstract][Full Text] [Related]
40. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
